Postsurgical follow-up and management
All patients with medullary thyroid carcinoma (MTC) should undergo calcitonin (CT) determination at regular intervals after total thyroidectomy. Within 6 weeks after operation serum CT measurement has to be performed to determine whether residual tumor or metastases are present (Fig. 1). Patients wi...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Kapitel/Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
1992
|
| In: |
Medullary thyroid carcinoma
Year: 1992, Pages: 197-211 |
| DOI: | 10.1007/978-3-642-84749-3_10 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-3-642-84749-3_10 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/chapter/10.1007/978-3-642-84749-3_10 
|
| Verfasserangaben: | F. Raue |
| Zusammenfassung: | All patients with medullary thyroid carcinoma (MTC) should undergo calcitonin (CT) determination at regular intervals after total thyroidectomy. Within 6 weeks after operation serum CT measurement has to be performed to determine whether residual tumor or metastases are present (Fig. 1). Patients with normal basal and pentagastrin-stimulated CT levels suggest a tumor-free state where no further treatment is necessary. They can then be followed-up at half-year intervals with physical examinations, and once a year a pentagastrin stimulation test has to be done (Grauer et al. 1990). |
|---|---|
| Beschreibung: | Gesehen am 15.04.2025 |
| Beschreibung: | Online Resource |
| ISBN: | 9783642847493 |
| DOI: | 10.1007/978-3-642-84749-3_10 |